Results 51 to 60 of about 6,779 (124)
Can Patients with Hematologic Disease and Prior Mucormycosis Undergo Stem Cell Transplantation?
Journal of FungiThe prognosis of mucormycosis after hematopoietic stem cell transplantation (HSCT) is generally poor but data on post-HSCT outcomes in patients with pre-HSCT mucormycosis are limited.
Armando Leon +5 more
doaj +1 more source
Frontiers in Neurology, 2020 Isolated cerebral mucormycosis is a clinical type of mucormycosis that is estimated to account for 8% of all mucormycosis cases. The clinical symptoms of isolated cerebral mucormycosis are elusive, and thus conventional techniques often lake sensitivity ...
Gao-jia Zhang +9 more
doaj +1 more source
Mycoses, Volume 69, Issue 9, September 2026.ABSTRACT Background Central nervous system (CNS) aspergillosis is a life‐threatening infection with mortality rates exceeding 50%, especially in immunocompromised patients. Significant challenges persist due to limited antifungal drug penetration into the CNS, emerging resistance, and diagnostic delays, despite advancements in therapy and diagnostics ...
Moustafa A. Mansour +5 more
wiley +1 more source
Avicenna Journal of Medicine, 2021 Mucormycosis (also known as black fungus) is caused by fungi of the Zygomycetes class and is the third most common invasive mycosis after candidiasis and aspergillosis. They colonize a large number of patients without invading them.
Suman Kumar Ray, Sukhes Mukherjee
doaj +1 more source
Mycoses, Volume 69, Issue 9, September 2026.ABSTRACT Fungal infections in Asia are influenced by warm, humid climates, high population density and expanding healthcare systems, which together facilitate the emergence, transmission and detection of both common and rare pathogens. While Candida and Aspergillus species remain the leading causes of invasive fungal disease, increasing attention has ...
Narut Chancharussin +3 more
wiley +1 more source
Journal of Infection and Public Health, 2022 Background: Mucormycosis is a life-threatening, invasive fungal disease that mostly affects immunocompromised hosts. In this study, we aimed to assess the clinical presentations and outcomes of patients with mucormycosis in a tertiary care hospital in ...
Hassan Almarhabi +7 more
doaj +1 more source
Clinical Case Reports, Volume 14, Issue 8, August 2026.ABSTRACT HLH must be suspected in liver transplant patients who exhibit fever, cytopenia, hyperferritinemia, and dysfunction of the graft. HLH‐2004 guidelines and H‐score assessment early on will aid in early diagnosis and management, although prognosis remains poor when there are opportunistic infections.
Saif Ali Malik +5 more
wiley +1 more source
An insight into the pathophysiology of mucormycosis: Lesson learnt during COVID pandemic
National Journal of Physiology, Pharmacy and PharmacologyMucormycosis, a lethal fungal infection caused by Rhizopus oryzae, has gained significant attention due to its association with the COVID-19 pandemic. The causal relationship between COVID-19 and mucormycosis is not yet fully understood.
Sukanti Bhattacharyya +2 more
doaj +1 more source
Investigating the Hepcidin Gene Polymorphisms in COVID-19-Associated Mucormycosis Susceptibility: A Clinical-Laboratory Study [PDF]
Iranian Journal of Medical SciencesBackground: Following the coronavirus disease 2019 outbreak (COVID-19), it became a worrisome health burden worldwide. COVID-19-associated mucormycosis emergence, characterized by dysregulated inflammation and iron metabolism, exacerbated the prognosis ...
Reyhaneh Ravanbakhsh +2 more
doaj +1 more source
Journal of Infection in Developing Countries, 2023 Introduction: There have been some reports of the association between SARS-CoV-2 infection and mucormycosis. This study aims to compare the hospitalization rates and clinical characteristics of mucormycosis before and during the COVID-19 pandemic ...
Mehrdad Estakhr +31 more
doaj +1 more source